Evercore ISI lowered the firm’s price target on Healthpeak Properties (DOC) to $24 from $26 and keeps an Outperform rating on the shares heading into Q4 healthcare REIT earnings report season. On the heels of Q3 reporting and recent conferences, the firm believes investors are focused on lab market updates and development leasing and tenant capital raising looking into 2025, the analyst says in a preview.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC:
- Healthpeak Properties price target lowered to $23 from $26 at Jefferies
- Healthpeak Properties price target lowered to $22 from $23 at Wells Fargo
- Healthpeak Properties Secures $3 Billion Credit Extension
- Healthpeak Properties price target lowered to $24 from $25 at Mizuho
- Healthpeak Properties Highlights 2024 Guidance at REITworld